MSA Capital is a global venture capital and private equity firm that invests in technology-enabled companies from seed to growth stage.
MSA Capital is a global venture capital and private equity firm that invests in technology-enabled companies from seed to growth stage. The firm manages capital from the world's top sovereign wealth funds, international asset managers, pension funds, university endowments, fund of funds, and family offices, as well as China's leading new economy entrepreneurs.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Jun 20, 2022
Yuanyin Bio
|
Series A | ¥280M | Biopharma | Yes |
Mar 30, 2021
Biren Technology
|
Series B | — | Hardware | — |
Dec 1, 2020
Newomics
|
Series B | $7.90M | Biotechnology | Yes |
Dec 21, 2018
Bosszhipin
|
Series E | $70M | Human Resources | — |
Jul 21, 2016
NIO
|
Series B | $316M | Automotive | — |